Abivax S.A.
Clinical trials sponsored by Abivax S.A., explained in plain language.
Abivax S.A.
ABVX
NASDAQ
Biotech developing treatments for inflammatory diseases and viral infections.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Healthy volunteers needed to Taste-Test a new drug pill Results expected Sep 2026 (estimated)
- New pill could tame Crohn's Flare-Ups Results expected Dec 2026 (estimated) May already have reported ↗